Abstract
The logistic modeling approach was used to describe experimental viable cell density (X) and product concentration (P) data from two industrial fed-batch mammalian cell culture processes with maximum product concentrations in the 3.0–9.4 g/l range. In both cases, experimental data were well described by the logistic equations and the resulting specific growth rate and protein productivity profiles provided useful insights into the process kinetics. Subsequently, sensitivity equations for both the X and P models were analyzed which helped characterize the influence of model parameters on X and P time courses. This was augmented by conventional sensitivity analyses where five values of each model parameter, 25% apart, were used to generate X and P time courses. Finally, results from sensitivity analysis were used to simulate X and P time courses that were reflective of typical early- and late-stage fed-batch cell culture processes. Different combinations of the logistic model parameters were used to arrive at the same final product concentration demonstrating the ability of the logistic approach to describe the multitude of process paths that result in the same final product concentration. Overall, the capability of the logistic equations to well describe X and P data from fed-batch cultures, coupled with their ability to simulate the multitude of paths leading up to the desired cell density and product concentration profiles, make them a useful tool during mammalian cell fed-batch process development.
Similar content being viewed by others
References
Adams CP, Brantner VV (2010) Spending on new drug development. Health Econ 19:130–141
Aggarwal S (2007) What’s fueling the biotech engine? Nat Biotechnol 25:1097–1104
Combs RG, Yu E, Roe S, Piatchek MB, Jones HL, Mott J, Kennard ML, Goosney DL, Monteith D (2011) Fed-batch bioreactor performance and cell line stability evaluation of the artificial chromosome expression technology expressing an IgG1 in Chinese hamster ovary cells. Biotechnol Prog 27:201–208
DiMasi R, Hansen HA, Grabwoski H (2003) The price of innovation: new estimates of drug development costs. J Health Econ 22:151–185
DiMasi R, Hansen R, Grabwoski H (2004) R&D costs and returns by therapeutic category. Drug Inf J 38:211–223
Goudar CT (2009) Robust parameter estimation during logistic modeling of batch and fed-batch culture kinetics. Biotechnol Prog 25:801–806
Goudar CT, Biener R, Konstantinov KB, Piret JM (2009) Error propagation from prime variables into specific rates and metabolic fluxes for mammalian cells in perfusion culture. Biotechnol Prog 25:986–998
Goudar CT, Joeris K, Konstantinov K, Piret JM (2005) Logistic equations effectively model mammalian cell batch and fed-batch kinetics by logically constraining the fit. Biotechnol Prog 21:1109–1118
Huang Y-M, Hu W, Rustandi E, Chang K, Yusuf-Makagiansar H, Ryll T (2010) Maximizing productivity of CHO cell-based fed-batch culture using chemically defined media conditions and typical manufacturing equipment. Biotechnol Prog 26:1400–1410
Kelley BD (2007) Very large scale monoclonal antibody purification: the case for conventional unit operations. Biotechnol Prog 23:995–1008
Kelley BD (2009) Industrialization of mAB production technology. The bioprocessing industry at a crossroads. mAbs 1:441–452
Kozlowski S, Swann P (2006) Current and future issues in the manufacturing and development of monoclonal antibodies. Adv Drug Deliv Rev 58:707–722
Krishnan M (2007) Monoclonal antibody gold rush. Curr Med Chem 14:1978–1987
Reichert JM (2009) Global antibody trends. mAbs 1:86–87
Acknowledgments
Insightful perspectives on the implications of final product concentration on process development and commercial manufacturing from Paul Wu, Harald Dinter, and Clive Wood, all of Bayer HealthCare, are appreciated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Goudar, C.T. Analyzing the dynamics of cell growth and protein production in mammalian cell fed-batch systems using logistic equations. J Ind Microbiol Biotechnol 39, 1061–1071 (2012). https://doi.org/10.1007/s10295-012-1107-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10295-012-1107-z